Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Biphenotypic, Acute 3Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid 2Leukemia, Lymphoid 2Burkitt Lymphoma 2Preleukemia 1Precancerous Conditions 1Neoplasms by Histologic Type 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoproliferative Disorders 1Lymphoma, Primary Effusion 1Lymphatic Diseases 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Mast-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Immunoproliferative Disorders 1Immune System Diseases 1Hematologic Neoplasms 1Hematologic Diseases 1GATA2 Deficiency 1Bone Marrow Diseases 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

Injections 3Cytarabine 3pegylated granulocyte colony-stimulating factor 2Decitabine 2Daunorubicin 2Cladribine 2Biopsy 2Azacitidine 2venetoclax 1ruxolitinib 1fludarabine phosphate 1fedratinib 1enasidenib 1Whole-Body Irradiation 1Tacrolimus 1Spinal Puncture 1Specimen Handling 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Mitoxantrone 1Liposomes 1Gemtuzumab 1Cyclophosphamide 1CPX-351 1Bone Marrow Transplantation 12'-chloro-2'-deoxyadenosine 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Monocytic, Acute × Bone Marrow Transplantation × 90 days × Clear all
NCT03670966 2026-05-04

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
30 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡